Lifeward Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LFWD research report →
Companygolifeward.com
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs.
- CEO
- William Mark Grant
- IPO
- 2014
- Employees
- 80
- HQ
- Yokneam Illit, IL
Price Chart
Valuation
- Market Cap
- $9.92M
- P/E
- -0.40
- P/S
- 0.47
- P/B
- 1.66
- EV/EBITDA
- -0.33
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 36.55%
- Op Margin
- -120.25%
- Net Margin
- -123.66%
- ROE
- -243.14%
- ROIC
- -86.31%
Growth & Income
- Revenue
- $22.03M · -14.14%
- Net Income
- $-19,914,000 · 31.19%
- EPS
- $-17.16 · 57.06%
- Op Income
- $-16,891,000
- FCF YoY
- 22.53%
Performance & Tape
- 52W High
- $15.84
- 52W Low
- $4.14
- 50D MA
- $6.81
- 200D MA
- $7.33
- Beta
- 0.33
- Avg Volume
- 14.24K
Get TickerSpark's AI analysis on LFWD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 1, 26 | Rose Keith Dale | other | 15,000 |
| May 1, 26 | Rose Keith Dale | other | 0 |
| Mar 25, 26 | ORAMED PHARMACEUTICALS INC. | other | 0 |
| Mar 25, 26 | ORAMED PHARMACEUTICALS INC. | other | 1,006,113 |
| Mar 25, 26 | ORAMED PHARMACEUTICALS INC. | other | 1,666,666 |
| Mar 25, 26 | ORAMED PHARMACEUTICALS INC. | other | 1,666,666 |
| Mar 25, 26 | Sigsbee William Mark | other | 11,485 |
| Mar 25, 26 | Sigsbee William Mark | other | 0 |
| Mar 25, 26 | Rozenbaum Moshe H | other | 11,485 |
| Mar 25, 26 | Rozenbaum Moshe H | other | 0 |
Our LFWD Coverage
We haven't published any research on LFWD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LFWD Report →